tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

60 Degrees Pharmaceuticals Inc

SXTP
Add to Watchlist
1.580USD
+0.100+6.76%
Close 07-27 16:00（ET）Quotes delayed by 15 min
4.17MMarket Cap
LossP/E TTM

60 Degrees Pharmaceuticals Inc

1.580
+0.100+6.76%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

SXTP Financials

See 60 Degrees Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

60 Degrees Pharmaceuticals Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-1.28/-0.76
Revenue / Forecast
162.09K/435.00K
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
1.41M
106.81%
EPS(YoY)
-11.74
84.18%
Analyst Rating
BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
17.43%-1.28
35.47%-1.47
42.89%-2.66
94.03%-1.26
-183.91%-1.55
89.66%-2.28
-110.12%-4.66
41.18%-21.14
106.61%1.85
---22.02
--46.04
---35.94
---28.01
----
---48.55
----
----
----
Revenue
-36.75%162.09K
21.01%316.38K
256.87%528.56K
144.93%307.87K
75.42%256.28K
512.17%261.44K
16.85%148.11K
100.64%125.70K
580.65%146.09K
--42.71K
-60.20%126.75K
67.36%62.65K
-86.93%21.46K
----
--318.45K
--37.43K
--164.17K
--286.64K
Net Profit
-11.02%-2.21M
28.00%-1.57M
-7.38%-2.44M
56.64%-1.86M
-738.12%-1.99M
-2.09%-2.18M
-155.77%-2.28M
-28.59%-4.29M
112.02%312.59K
---2.13M
381.98%4.08M
-55.41%-3.34M
-185.01%-2.60M
----
---1.45M
---2.15M
---912.28K
---1.36M
Net Margin
-76.04%-1289.49%
41.96%-454.85%
69.95%-438.37%
83.03%-563.52%
-350.04%-732.51%
83.64%-783.71%
-144.30%-1458.70%
37.78%-3320.78%
102.42%292.95%
---4791.29%
--3292.63%
---5337.11%
---12101.82%
----
---866.86%
----
----
----
Gross Margin
-34.02%47.12%
12.80%61.86%
-107.02%-1.73%
191.30%83.74%
29.34%71.41%
122.62%54.84%
-43.89%24.59%
114.84%28.75%
122.94%55.21%
---242.47%
--43.83%
---193.67%
---240.66%
----
--48.17%
----
----
----
Debt to assets ratio
-13.50%2.25%
5.18%2.85%
8.88%2.30%
1.38%3.69%
37.55%2.60%
32.49%2.71%
19.71%2.11%
-98.99%3.64%
-99.41%1.89%
-99.88%2.04%
--1.76%
--358.71%
--319.47%
--1742.24%
--1273.15%
----
----
----
Income Statement
Revenue
-36.75%162.09K
21.01%316.38K
256.87%528.56K
144.93%307.87K
75.42%256.28K
512.17%261.44K
16.85%148.11K
100.64%125.70K
580.65%146.09K
--42.71K
-60.20%126.75K
67.36%62.65K
-86.93%21.46K
----
--318.45K
--37.43K
--164.17K
--286.64K
Operating profit
-9.63%-2.09M
7.63%-1.92M
-9.76%-2.33M
61.69%-1.60M
-43.50%-1.91M
-9.59%-2.08M
-39.23%-2.12M
-431.57%-4.19M
-40.08%-1.33M
---1.89M
-607.41%-1.52M
-14.71%-788.00K
-480.69%-950.66K
----
---215.12K
---686.92K
---163.71K
---481.89K
Net Profit
-11.02%-2.21M
28.00%-1.57M
-7.38%-2.44M
56.64%-1.86M
-738.12%-1.99M
-2.09%-2.18M
-155.77%-2.28M
-28.59%-4.29M
112.02%312.59K
---2.13M
381.98%4.08M
-55.41%-3.34M
-185.01%-2.60M
----
---1.45M
---2.15M
---912.28K
---1.36M
Balance Sheet
Current assets
10.80%6.26M
-9.11%4.90M
-8.44%6.31M
2.16%3.84M
-28.53%5.65M
-25.63%5.39M
-22.53%6.89M
-33.69%3.76M
36.43%7.91M
559.01%7.24M
484.55%8.89M
--5.67M
--5.79M
--1.10M
--1.52M
----
----
----
Total current liabilities
4.06%1.88M
11.20%1.84M
67.72%2.20M
38.68%1.69M
63.24%1.80M
-41.55%1.66M
-47.20%1.31M
-95.78%1.22M
-95.68%1.10M
-88.15%2.84M
18.99%2.48M
--28.86M
--25.54M
--23.92M
--2.09M
----
----
----
Total assets
13.14%6.76M
-6.83%5.37M
-9.86%6.69M
-3.36%4.18M
-28.66%5.98M
-26.01%5.76M
-18.90%7.42M
-41.20%4.33M
10.44%8.38M
500.04%7.78M
441.87%9.15M
--7.36M
--7.59M
--1.30M
--1.69M
----
----
----
Total liabilities
3.59%2.02M
10.11%1.99M
60.65%2.34M
34.24%1.84M
55.47%1.95M
-39.57%1.80M
-44.64%1.46M
-95.48%1.37M
-95.38%1.25M
-88.27%2.99M
-89.00%2.63M
--30.24M
--27.12M
--25.45M
--23.94M
----
----
----
Total equity
17.76%4.74M
-14.55%3.38M
-27.10%4.35M
-20.74%2.35M
-43.46%4.03M
-17.57%3.96M
-8.49%5.96M
112.94%2.96M
136.48%7.13M
119.87%4.80M
129.29%6.52M
---22.88M
---19.53M
---24.15M
---22.25M
----
----
----
Cash Flow Statement
Net operating income
-71.63%-2.74M
-3.31%-1.69M
-25.45%-2.11M
-22.04%-1.45M
-40.07%-1.60M
-2473.06%-1.64M
55.20%-1.68M
-279.03%-1.19M
-176.35%-1.14M
3.50%-63.67K
-1122.26%-3.75M
41.34%-313.49K
-302.38%-412.68K
78.82%-65.98K
---307.06K
---534.39K
---102.56K
---311.46K
Net investment
-29.89%1.19M
-65220.83%-1.37M
98.54%-25.49K
60.41%-51.68K
17447.85%1.70M
96.85%-2.10K
-6158.80%-1.75M
-620.25%-130.56K
-198.12%-9.81K
-13.50%-66.56K
-2066.67%-27.91K
-771.07%-18.13K
-298.55%-3.29K
-3243.50%-58.65K
--1.42K
---2.08K
---826.00
---1.75K
Net financing
98.58%3.37M
47034.02%458.61K
-16.85%4.28M
100.00%0.00
-10.84%1.70M
--973.00
-13.75%5.15M
-100.27%-865.00
943.54%1.90M
100.00%0.00
--5.97M
-75.12%321.07K
--182.39K
-181.85%-68.63K
--0.00
--1.29M
--0.00
--83.84K

FAQs

What is the total revenue of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 1.41M, with a year-on-year change of 681.34K.

What are the current assets of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its current assets were 4.90M, with a year-on-year change of -9.11.

What are the total assets of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its total assets of 60 Degrees Pharmaceuticals Inc were 5.37M, with a year-on-year change of -6.83.

What are the total liabilities of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of 60 Degrees Pharmaceuticals Inc were 1.99M, with a year-on-year change of 10.11.

What is the total equity of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its total equity of 60 Degrees Pharmaceuticals Inc was 3.38M, with a year-on-year change of -14.55.

What is the net operating income of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its net operating income of 60 Degrees Pharmaceuticals Inc was -7.76M, with a year-on-year change of 20.14.

What is the net investment of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its net investment of 60 Degrees Pharmaceuticals Inc was 254.92K, with a year-on-year change of 113.49.

What is the net financing of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its net financing of 60 Degrees Pharmaceuticals Inc was 6.44M, with a year-on-year change of -8.73.

What is the Earnings Per Share (EPS) of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -11.74, with a year-on-year change of 84.18.

What is the net income of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its net income was -7.87M, with a year-on-year change of 6.69.

What is the net margin of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -522.91, with a year-on-year change of 55.22.

What is the gross margin of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 44.53, with a year-on-year change of 2.29.

What is the debt-to-asset ratio of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 2.85, with a year-on-year change of 5.18.

What is the Return on Assets (ROA) of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -132.46, with a year-on-year change of -12.74.

What is the operating profit of 60 Degrees Pharmaceuticals Inc?

According to 60 Degrees Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -7.76M, with a year-on-year change of 20.14.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy